Two‐stage randomized trial design for testing treatment, preference, and self‐selection effects for count outcomes

Abstract

While the traditional clinical trial design lays emphasis on testing the treatment effect between randomly assigned groups, it ignores the role of patient preference for a particular treatment in the trial. Yet, for healthcare providers who seek to optimize the patient-centered treatment strategy, the evaluation of a patient's psychology toward each treatment could be a key consideration. The two-stage randomized trial design allows researchers to test patient's preference and selection effects, in addition to the treatment effect. The current methodology for the two-stage design is limited to continuous and binary outcomes; this article extends the model to include count outcomes. The test statistics for preference, selection, and treatment effects are derived. Closed-form sample size formulae are presented for each effect. Simulations are presented to demonstrate the properties of the unstratified and stratified designs. Finally, we apply methods to the use of antimicrobials at the end of life to demonstrate the applicability of the methods.

Trade Flow Optimization Model for Plastic Pollution Reduction

“…The baseline of no trade is shown in Appendix A — Figure A4 . The additional improvements from more trade indicates the impacts of easing trade limits ([ 17 ]). First, we observe that none of the countries suffered from more contributions to global plastic pollution.…”

Likelihood based inferences for trials incorporating participant’s treatment choice

“…Later, Cameron et al [2] extended Rücker’s work to binary outcomes and allowed for stratification in the model. Shi et al [6] extended it to count outcomes, more specifically Poisson. To date, we do not believe anyone extended the ANOVA method for these designs to a version that accommodates covariates.…”